Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 160
- −2 vs. Q3 2024
- Portfolio value
- $5.19B
- −$977.4M (−15.8%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 593,184 | $364.8M | 7.0% | −39,645−6.3% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 7,868,700 | $275.1M | 5.3% | −5,700−0.1% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,820,000 | $248.4M | 4.8% | −43,800−2.4% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 464,377 | $242.4M | 4.7% | −32,398−6.5% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,440,240 | $203.8M | 3.9% | −45,387−1.8% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 487,434 | $196.3M | 3.8% | −83,972−14.7% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 4,386,900 | $191.9M | 3.7% | −484,460−9.9% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,688,660 | $191.0M | 3.7% | −55,278−3.2% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 2,135,295 | $190.7M | 3.7% | −317,502−12.9% | Reduced | History |
| SYKStryker Corp | Stock | 520,026 | $187.2M | 3.6% | −6,581−1.2% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 770,268 | $181.3M | 3.5% | −38,827−4.8% | Reduced | History |
| INCYIncyte Corp | COM | 2,157,478 | $149.0M | 2.9% | +6,927+0.3% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 3,515,150 | $115.5M | 2.2% | −220,765−5.9% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 2,510,690 | $108.5M | 2.1% | +349,487+16.2% | Added | History |
| PODDInsulet Corp | Stock | 321,917 | $84.0M | 1.6% | −99,562−23.6% | Reduced | History |
| MDTMedtronic plc | Stock | 1,042,948 | $83.3M | 1.6% | +34,315+3.4% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 1,097,848 | $81.3M | 1.6% | −36,228−3.2% | Reduced | History |
| DXCMDexcom Inc | COM | 1,045,044 | $81.3M | 1.6% | +28,006+2.8% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 159,713 | $80.8M | 1.6% | −65,837−29.2% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,071,615 | $77.6M | 1.5% | 00.0% | Unchanged | History |
| BDXBecton Dickinson & Co | Stock | 337,548 | $76.6M | 1.5% | −850.0% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 2,040,853 | $76.2M | 1.5% | 00.0% | Unchanged | History |
| MRNAModerna, Inc. | Stock | 1,600,877 | $66.6M | 1.3% | +410.0% | Added | History |
| PENPenumbra Inc | COM | 238,053 | $56.5M | 1.1% | −34,630−12.7% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 4,094,458 | $50.6M | 1.0% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 2,389,600 | $45.8M | 0.9% | +3,000+0.1% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 524,414 | $41.0M | 0.8% | −7,553−1.4% | Reduced | History |
| EXASExact Sciences Corp | COM | 694,056 | $39.0M | 0.8% | −755,409−52.1% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,428,929 | $38.2M | 0.7% | 00.0% | Unchanged | History |
| BEAMBeam Therapeutics Inc. | COM | 1,518,121 | $37.6M | 0.7% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 462,894 | $37.3M | 0.7% | −149,797−24.4% | Reduced | History |
| RMDResmed Inc | COM | 160,793 | $36.8M | 0.7% | +665+0.4% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 1,205,464 | $35.6M | 0.7% | 00.0% | Unchanged | History |
| LLYEli Lilly & Co | Stock | 45,465 | $35.1M | 0.7% | +1,219+2.8% | Added | History |
| CICigna Group | Stock | 125,205 | $34.6M | 0.7% | +6,798+5.7% | Added | History |
| ALGNAlign Technology Inc | COM | 160,003 | $33.4M | 0.6% | +16,007+11.1% | Added | History |
| COOCooper Companies, Inc. | COM | 357,130 | $32.8M | 0.6% | −40,243−10.1% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,929,963 | $32.3M | 0.6% | 00.0% | Unchanged | History |
| IDXXIDEXX Laboratories Inc | COM | 76,935 | $31.8M | 0.6% | −14,344−15.7% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 60,962 | $31.7M | 0.6% | +7,339+13.7% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 293,621 | $31.0M | 0.6% | −139,184−32.2% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 7,377,292 | $30.4M | 0.6% | +1080.0% | Added | History |
| GMEDGlobus Medical Inc | Stock | 362,979 | $30.0M | 0.6% | −106,819−22.7% | Reduced | History |
| CDNACareDx, Inc. | COM | 1,374,412 | $29.4M | 0.6% | −1,771,044−56.3% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 782,456 | $28.2M | 0.5% | −1,068,435−57.7% | Reduced | History |
| DHRDanaher Corp | Stock | 119,922 | $27.5M | 0.5% | +14,332+13.6% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 148,478 | $27.5M | 0.5% | −46,602−23.9% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 127,575 | $26.8M | 0.5% | −35,937−22.0% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $26.5M | 0.5% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 568,955 | $26.4M | 0.5% | −651,104−53.4% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 264,226 | $26.3M | 0.5% | +221,993+525.6% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 4,460,693 | $24.2M | 0.5% | 00.0% | Unchanged | History |
| MOHMolina Healthcare, Inc. | COM | 82,151 | $23.9M | 0.5% | +14,589+21.6% | Added | History |
| AMGNAmgen Inc | Stock | 89,240 | $23.3M | 0.4% | +64,088+254.8% | Added | History |
| NTRANatera, Inc. | COM | 145,676 | $23.1M | 0.4% | +7,217+5.2% | Added | History |
| STESTERIS plc | SHS USD | 109,887 | $22.6M | 0.4% | +18,605+20.4% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 31,412 | $22.4M | 0.4% | +4,636+17.3% | Added | History |
| ESPREsperion Therapeutics, Inc. | COM | 9,944,064 | $21.9M | 0.4% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 329,021 | $21.6M | 0.4% | −1,955−0.6% | Reduced | History |
| BRKRBruker Corp | COM | 359,588 | $21.1M | 0.4% | +359,588 | New | History |
| SRPTSarepta Therapeutics, Inc. | COM | 171,317 | $20.8M | 0.4% | −173,031−50.2% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 745,982 | $19.9M | 0.4% | −516,048−40.9% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 953,164 | $18.6M | 0.4% | −106,007−10.0% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 61,883 | $18.6M | 0.4% | −52,642−46.0% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,517,839 | $18.2M | 0.4% | 00.0% | Unchanged | History |
| HOLXHologic Inc | COM | 247,886 | $17.9M | 0.3% | +220.0% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 258,483 | $17.8M | 0.3% | −266,951−50.8% | Reduced | History |
| CORCencora, Inc. | Stock | 77,522 | $17.4M | 0.3% | +5,469+7.6% | Added | History |
| EHCEncompass Health Corp | COM | 188,522 | $17.4M | 0.3% | +169,289+880.2% | Added | History |
| NEONeogenomics Inc | COM NEW | 1,055,796 | $17.4M | 0.3% | −556,816−34.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 38,343 | $14.1M | 0.3% | −50,985−57.1% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 110,230 | $13.9M | 0.3% | +104,605+1,859.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 485,050 | $13.2M | 0.3% | −144,708−23.0% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 1,113,658 | $12.5M | 0.2% | −1,556,392−58.3% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 880,979 | $12.4M | 0.2% | −563,130−39.0% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 192,718 | $12.0M | 0.2% | +22,874+13.5% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 33,551 | $11.0M | 0.2% | −12,600−27.3% | Reduced | History |
| MCKMcKesson Corp | Stock | 19,315 | $11.0M | 0.2% | −16,427−46.0% | Reduced | History |
| PHRPhreesia, Inc. | COM | 405,693 | $10.2M | 0.2% | −16,713−4.0% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 118,930 | $10.1M | 0.2% | −248,251−67.6% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 50,327 | $9.29M | 0.2% | −22,788−31.2% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 60,875 | $9.13M | 0.2% | −2,108−3.3% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 44,833 | $8.81M | 0.2% | −84,994−65.5% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 45,259 | $8.04M | 0.2% | +2,373+5.5% | Added | History |
| FATEFate Therapeutics Inc | COM | 4,839,779 | $7.99M | 0.2% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 54,557 | $7.89M | 0.2% | +3,315+6.5% | Added | History |
| HUMHumana Inc | Stock | 28,367 | $7.20M | 0.1% | −73−0.3% | Reduced | History |
| ALTAltimmune, Inc. | COM NEW | 945,446 | $6.82M | 0.1% | +81,786+9.5% | Added | History |
| ASTHAstrana Health, Inc. | COM NEW | 205,239 | $6.47M | 0.1% | −48,943−19.3% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 34,229 | $6.32M | 0.1% | −24,500−41.7% | Reduced | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,061,753 | $5.88M | 0.1% | +19,618+1.9% | Added | History |
| ILMNIllumina, Inc. | COM | 43,703 | $5.84M | 0.1% | −1,493−3.3% | Reduced | History |
| WAYWaystar Holding Corp. | COM | 157,898 | $5.79M | 0.1% | +7,696+5.1% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 167,341 | $5.45M | 0.1% | −1,793−1.1% | Reduced | History |
| CNCCentene Corp | Stock | 86,456 | $5.24M | 0.1% | −252−0.3% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 48,429 | $4.47M | 0.1% | +2,402+5.2% | Added | History |
| OMCLOmnicell, Inc. | COM | 94,740 | $4.22M | 0.1% | −102,974−52.1% | Reduced | History |
| MASIMasimo Corp | COM | 24,166 | $3.99M | 0.1% | +24,166 | New | History |
| TXG10x Genomics, Inc. | CL A COM | 270,728 | $3.89M | 0.1% | −11,153−4.0% | Reduced | History |
| PFEPfizer Inc | Stock | 141,560 | $3.76M | 0.1% | +485+0.3% | Added | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Moderna Inc60770K907 | CALL | – | $110.0K |
Sold out since Q3 2024 (14)
Positions held at the end of Q3 2024 that are gone from this filing.
| Security | Class | Shares in Q3 2024 | Value in Q3 2024 | % of portfolio in Q3 2024 | History |
|---|---|---|---|---|---|
| OPCHOption Care Health, Inc. | COM NEW | 1,654,878 | $51.8M | 0.8% | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,879,583 | $47.8M | 0.8% | History |
| EXELExelixis, Inc. | COM | 1,600,000 | $41.5M | 0.7% | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 610,000 | $28.7M | 0.5% | History |
| GBIOGeneration Bio Co. | COM | 3,918,856 | $9.68M | 0.2% | History |
| MTEMMolecular Templates, Inc. | COM NEW | 1,279,820 | $1.80M | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 15,109 | $870.7K | <0.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 19,046 | $549.3K | <0.1% | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 24,015 | $469.0K | <0.1% | History |
| VTRSViatris Inc | Stock | 39,283 | $456.1K | <0.1% | History |
| NKENIKE, Inc. | Stock | 3,500 | $309.4K | <0.1% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 7,200 | $228.1K | <0.1% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 9,300 | $171.8K | <0.1% | History |
| OABIOmniAb, Inc. | COM | 11,456 | $48.5K | <0.1% | History |